Gradientech starts pre-clinical testing in the US
The diagnostics company Gradientech today announces the starting of pre-clinical testing in the US.Following the CE-IVD registration of the QuickMIC® system and gram-negative (GN) panel, the commercialisation has started in select European markets. While in Europe most laboratories follow the European Committee on Antimicrobial Susceptibility Testing (EUCAST) guidelines, in the United States antimicrobial susceptibility testing is overwhelmingly performed according to criteria determined by the Clinical and Laboratory Standards Institute (CLSI). In addition to these different governing